Clinical trials

  • FARLETUZUMAB ECTERIBLIN for Platinum-resistant ovarian cancer | Triple-negative breast cancer | Endometrial cancer | Non-small cell lung cancer (adenocarcinoma)
  • BEPIROVIRSEN for Chronic hepatitis B
  • ALECTINIB for ALK-positive non-small cell lung cancer | Resected stage Ib–IIIa non-small cell lung cancer
  • BENZYLPENICILLIN SODIUM for Staphylococcus aureus bacteraemia | Staphylococcus aureus bacteremia
  • NIRAPARIB, ABIRATERONE ACETATE for Prostate cancer | Metastatic hormone-sensitive prostate cancer | Metastatic castration-resistant prostate cancer
  • Amikacin for Mycobacterium xenopi pulmonary infection
  • MK-4830 for Renal cell carcinoma
  • HUMAN PAPILLOMAVIRUS TYPE 31 L1 PROTEIN - ADSORBED; HUMAN PAPILLOMAVIRUS TYPE 33 L1 PROTEIN - ADSORBED; HUMAN PAPILLOMAVIRUS TYPE 45 L1 PROTEIN - ADSORBED; HUMAN PAPILLOMAVIRUS TYPE 52 L1 PROTEIN - ADSORBED; HUMAN PAPILLOMAVIRUS TYPE 58 L1 PROTEIN - ADSORBED; HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN - ADSORBED; HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN - ADSORBED; HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN - ADSORBED; HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN - ADSORBED for Vulvar high-grade squamous intraepithelial lesion (vHSIL)
  • Macitentan for Pulmonary arterial hypertension
  • HEXAMINOLEVULINATE for Non-muscle invasive bladder cancer
  • LISDEXAMFETAMINE DIMESYLATE for Attention-deficit hyperactivity disorder|Type 1 diabetes mellitus
  • SOMAPACITAN for Short stature in children born small for gestational age (SGA)